Patricia Renard Selected Research

Calcium Chelating Agents

1/2003	Role of ERK and calcium in the hypoxia-induced activation of HIF-1.
11/2002	ERK and calcium in activation of HIF-1.
1/2002	Identification of the phospholipase A(2) isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A(2) inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Renard Research Topics

Disease

6	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 06/2005
3	Neoplasms (Cancer) 01/2020 - 09/2014
3	Obesity 02/2018 - 01/2009
3	Hypoxia (Hypoxemia) 01/2003 - 01/2002
2	Infections 01/2022 - 01/2013
2	Nervous System Diseases (Neurological Disorders) 09/2014 - 06/2012
2	Hypersensitivity (Allergy) 01/2012 - 05/2011
2	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 01/2012 - 06/2005
1	Hypertrophy 02/2018
1	Adenocarcinoma 10/2016
1	Parasitic Diseases (Parasitic Disease) 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Inflammation (Inflammations) 06/2012
1	Tauopathies 06/2012
1	Alzheimer Disease (Alzheimer's Disease) 06/2012
1	MELAS Syndrome (Syndrome, MELAS) 01/2012
1	Lymphoma (Lymphomas) 05/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2011
1	Multiple Symmetrical Lipomatosis (Lipomatosis, Familial Benign Cervical) 06/2005
1	Mitochondrial cytopathy 06/2005
1	Ischemia 01/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
4	CalciumIBA 01/2012 - 01/2002
3	Mitochondrial DNA (mtDNA)IBA 01/2020 - 05/2011
3	Triglycerides (Triacylglycerol)IBA 02/2018 - 06/2005
3	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 11/2002
3	1,2- bis(2- aminophenoxy)ethane- N,N,N',N'- tetraacetic acid (BAPTA)IBA 01/2003 - 01/2002
3	Calcium Chelating AgentsIBA 01/2003 - 01/2002
2	Caspase 3 (Caspase-3)IBA 01/2013 - 05/2011
2	MicroRNAs (MicroRNA)IBA 01/2013 - 06/2012
2	StaurosporineIBA 01/2012 - 05/2011
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2003 - 11/2002
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2003 - 11/2002
2	IonomycinIBA 01/2003 - 11/2002
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Mitochondrial Uncoupling ProteinsIBA 01/2019
1	EnzymesIBA 10/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2016
1	AntioxidantsIBA 10/2016
1	Oxygen (Dioxygen)IBA 10/2016
1	CatalaseIBA 10/2016
1	Protein AggregatesIBA 09/2014
1	Adenosine Triphosphate (ATP)IBA 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014
1	tau Proteins (tau Protein)IBA 06/2012
1	Cytochromes c (Cytochrome c)IBA 01/2012
1	CaspasesIBA 01/2012
1	Etoposide (VP 16)FDA LinkGeneric 01/2012
1	Cathepsin BIBA 05/2011
1	LipidsIBA 01/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2005
1	Glucose (Dextrose)FDA LinkGeneric 06/2005
1	W 7 (W7)IBA 01/2003
1	Phosphotransferases (Kinase)IBA 11/2002
1	KN 93IBA 11/2002
1	Transcription Factors (Transcription Factor)IBA 11/2002
1	Calcium-Independent Phospholipases A2IBA 01/2002
1	Cycloheximide (Cicloheximide)IBA 01/2002
1	ProstaglandinsIBA 01/2002
1	arachidonyltrifluoromethaneIBA 01/2002
1	Secretory Phospholipases A2IBA 01/2002
1	Messenger RNA (mRNA)IBA 01/2002
1	Prostaglandins FIBA 01/2002
1	Phospholipases (Phospholipase)IBA 01/2002